Literature DB >> 1351031

Huntington disease in Finland: a molecular and genealogical study.

E Ikonen1, J Ignatius, R Norio, J Palo, L Peltonen.   

Abstract

Huntington disease (HD) is found at exceptionally low frequency in the Finnish population. In this population, linkage disequilibrium was earlier established with markers from the D4S10 and D4S43 loci. We now report a continuation to the restriction fragment length polymorphism haplotype analysis, in combination with a genealogical study of all the Finnish HD families. When the HD pedigrees were systematically traced to the 18th century, only one consanguinity was found, and a high percentage (28%) of the families had foreign ancestors. The majority of the Finnish ancestors were localized to border regions or trade centers of the country following the old postal routes. The observed high risk haplotypes formed with markers from the D4S10 and D4S43 loci were evenly distributed among the HD families in different geographical locations. Consequently, the HD gene(s) has most probably arrived in Finland on several occasions via foreign immigrants during the last few centuries.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351031     DOI: 10.1007/bf00220539

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  19 in total

1.  Studies on DNA markers (D4S10 and D4S43/S127) genetically linked to Huntington's disease in Japanese families.

Authors:  I Kanazawa; I Kondo; J E Ikeda; T Ikeda; Y Shizu; M Yoshida; H Narabayashi; S Kuroda; H Tsunoda; E Mizuta
Journal:  Hum Genet       Date:  1990-08       Impact factor: 4.132

2.  Recombination events suggest potential sites for the Huntington's disease gene.

Authors:  M E MacDonald; J L Haines; M Zimmer; S V Cheng; S Youngman; W L Whaley; N Wexler; M Bucan; B A Allitto; B Smith
Journal:  Neuron       Date:  1989-08       Impact factor: 17.173

3.  Cystic fibrosis in Finland: a molecular and genealogical study.

Authors:  J Kere; R Norio; E Savilahti; X Estivill; A de la Chapelle
Journal:  Hum Genet       Date:  1989-08       Impact factor: 4.132

4.  Low prevalence of Huntington's disease in Finland.

Authors:  J Palo; H Somer; E Ikonen; L Karila; L Peltonen
Journal:  Lancet       Date:  1987-10-03       Impact factor: 79.321

5.  Increased recombination adjacent to the Huntington disease-linked D4S10 marker.

Authors:  B A Allitto; M E MacDonald; M Bucan; J Richards; D Romano; W L Whaley; B Falcone; J Ianazzi; N S Wexler; J J Wasmuth
Journal:  Genomics       Date:  1991-01       Impact factor: 5.736

6.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

7.  A polymorphic DNA marker genetically linked to Huntington's disease.

Authors:  J F Gusella; N S Wexler; P M Conneally; S L Naylor; M A Anderson; R E Tanzi; P C Watkins; K Ottina; M R Wallace; A Y Sakaguchi
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

8.  The prevalence of Huntington's chorea in South Africa.

Authors:  M R Hayden; J M MacGregor; P H Beighton
Journal:  S Afr Med J       Date:  1980-08-02

9.  Linkage disequilibrium and modification of risk for Huntington disease.

Authors:  S Adam; J Theilmann; K Buetow; A Hedrick; C Collins; B Weber; M Huggins; M Hayden
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

10.  Huntington disease in Finland: linkage disequilibrium of chromosome 4 RFLP haplotypes and exclusion of a tight linkage between the disease and D4S43 locus.

Authors:  E Ikonen; J Palo; J Ott; J Gusella; H Somer; L Karila; A Palotie; L Peltonen
Journal:  Am J Hum Genet       Date:  1990-01       Impact factor: 11.025

View more
  1 in total

1.  Geographical distribution of haplotypes in Swedish families with Huntington's disease.

Authors:  E Almqvist; S Andrew; J Theilmann; P Goldberg; J Zeisler; U Drugge; U Grandell; M Tapper-Persson; B Winblad; M Hayden
Journal:  Hum Genet       Date:  1994-08       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.